Edition:
United Kingdom

Genfit SA (GNFT.PA)

GNFT.PA on Paris Stock Exchange

22.46EUR
22 Mar 2019
Change (% chg)

€-0.64 (-2.77%)
Prev Close
€23.10
Open
€23.12
Day's High
€23.26
Day's Low
€22.38
Volume
221,189
Avg. Vol
195,283
52-wk High
€25.88
52-wk Low
€15.54

Chart for

About

Genfit SA is a France-based biopharmaceutical company that specializes in the development of medicines for the prevention and treatment of diabetes and related disorders. The Company is focused on contributing to bringing medicines to market for patients with metabolic, inflammatory, autoimmune and fibrotic diseases that affect... (more)

Overall

Beta: 1.59
Market Cap(Mil.): €769.50
Shares Outstanding(Mil.): 31.17
Dividend: --
Yield (%): --

Financials

  GNFT.PA Industry Sector
P/E (TTM): -- 69.32 32.54
EPS (TTM): -1.49 -- --
ROI: -38.89 8.89 13.82
ROE: -41.34 10.02 15.24

Earnings vs. Estimates